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Similarly anti nitric oxide agents failed in a long term study to slow
down the progression of knee OA.
Owing to these repeated negative results with biologics, new strategies
should be contemplated such as gene therapy.
On the other hand, new emerging treatments may be more related on
the repair side of cartilage. This could be targeted by using growth factor
delivery. Intra articular administration of autologous platelets is widely
used by the level of proofs still need to be conﬁrmed in large
randomized trials. One placebo controlled study using repeated intra
articular administration of FGF 18 failed to demonstrate neither any
pain relief nor any structural changes. The therapeutically option con-
sisting in the intra articular administration of autologous stem cells is
ongoing in a phase 1 study in humans. In the next future, new lubricants
agents such recombinant lubricin also offers an appealing approach.
Finally, recent placebo controlled study with ranelate strontium,
a decoupling bone agent, showed promising results on the evolution of
joint space narrowing in patients with knee OA.
Conclusions: Looking for new treatments options in OA should not only
consider new drugs with an appealing mechanism of action but should
also consider to whom patient and when those therapies could be at
best prescribed.
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A STEM CELL-BASED APPROACH TO CARTILAGE REPAIR
K.A. Johnson. Genomics Inst. of the Novartis Res. Fndn., San Diego, CA, USA
Osteoarthritis (OA) is a degenerative joint disease that involves
destruction of articular cartilage and eventually leads to disability.
Molecules that promote the selective differentiation of multi-potent
mesenchymal stem cells (MSCs) in to chondrocytes may stimulate the
repair of damaged cartilage. Using an image-based, high throughput
screen we identiﬁed the small molecule kartogenin, which promotes
selective chondrocytes differentiation (EC50 ¼ 100 nM), shows chon-
dro-protective effects in vitro, and is efﬁcacious in two OA animal
models. Kartogenin binds ﬁlamin A (FLNA), disrupts its interaction with
the transcription factor CBFb and induces chondrogenesis by regulating
the CBFb-RUNX1 transcriptional program. This work provides new
insight into the control of chondrogenesis that may ultimately lead to
a stem-cell based therapy for osteoarthritis.
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SURGICAL ASPECTS OF OA (MENISCUS)
M. Englund y,z. y Lund Univ., Lund, Sweden; zBoston Univ. Sch. of Med.,
Boston, MA, USA
The menisci are internal structures that are of central importance for
a healthy knee joint; they have a key role in the structural progression
of knee osteoarthritis (OA), and the risk of the disease dramatically
increases if they are damaged by injury or degenerative processes.
Meniscus damage might be considered a signifying feature of incipient
OA in middle-aged and elderly people. As approximately every third
knee of people in this group has a damaged meniscus, tears are
common incidental ﬁndings of knee MRI. However, as most tears do not
cause symptoms, careful clinical evaluation is required to determine if
a damaged meniscus is likely to directly impact a patient's symptoms.
Conservative management of patients with knee pain and a degenera-
tive meniscal tear should be considered as a ﬁrst-line therapy before
surgical treatment is contemplated. Patients with mechanical interfer-
ence of joint movements, such as painful catching or locking, might
need surgical treatment with meniscal repair if possible. In a subset of
patients, meniscal resection might relieve pain and other symptoms
that potentially originate directly from the torn meniscus. However, the
possibility of an increased risk of OA if functional meniscal tissue is
removed cannot be overlooked.
I-12
AUTOPHAGY IN THE PATHOGENESIS OF AGING-RELATED OA
B. Caramés. Osteoarticular and Aging Res. Lab., INIBIC – Inst. of BioMed.
Res. of A Coruña, A Coruña, Spain
Although aging represents one of the most important risk factor for OA,
mechanisms leading to aging-related cartilage degeneration remain to
be determined. Consequently, there are no approaches to target aging-related changes in cartilage therapeutically, even in preclinical experi-
mental models. Autophagy plays a fundamental role in cellular
homeostasis and organismal health. It is a major physiological mecha-
nism that eliminates altered and dysfunctional cytosolic macromole-
cules, membranes and organelles by lysosomal degradation. In most
experimental models, suppression of relevant autophagy genes leads to
cell death, indicating a protective and survival-promoting function. In
articular cartilage, which is characterized by a very low rate of cell
turnover this mechanism appears to be essential to maintain cellular
integrity, function and survival. Furthermore, while aging-related
changes in autophagy have been demonstrated in various models and
tissues, this is only the beginning of studies focus on articular cartilage.
Our recent observations in human knee joints and in experimental
models indicate that aging and OA are associated with defective auto-
phagy in articular cartilage. This provides a unique opportunity to study
a new dimension of cartilage aging mechanisms and simultaneously
explore the therapeutic potential of pharmacological enhancement of
autophagy in OA.
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OPTIMAL COMBINATIONS OF SCAFFOLDS AND GROWTH FACTORS
FOR TISSUE ENGINEERING OF CARTILAGE
K. Hoshi. The Univ. of Tokyo, Tokyo, Japan
Purpose: Since cartilage has poor regenerative capacity by itself, its
regeneration using a tissue engineering technique may greatly beneﬁt
the treatment of various cartilage disorders that cannot be treated by
conventional methods. Although autologous chondrocyte trans-
plantation has been already available for clinical use, the size is limited
to a ﬁller of focal articular cartilage defect or an injectable material for
the nasal cosmetic augmentation. In order to broaden its clinical indi-
cation to major disorders such as osteoarthritic joints, microtia or cleft
lip/palate, we should make an “implant-type” tissue-engineered carti-
lage with a greater ﬁrmness and a 3D-structure.
Methods: For that, we developed 1) a proliferation medium for
chondrocytes to realize a more than 1000-fold increase in number
without using fetal bovine serum that has been restricted to clinical
application, and 2) a scaffold system that effectively preserves chon-
drocytes in the engineered tissue and provides the adequate 3D shape
to the tissue.
Results: For the proliferation medium, we examined the optimal
combination from 12 putative soluble chondrocyte regulators including
FGF-2, IGF-I, insulin, BMP-2, PTH and others. Using the statistical
method that is termed “analysis of variance by fractional factorial
design”, the effects of the individual factors and the synergy of the
combinations were evaluated. As a result, the combination of FGF-2 and
insulin with 5% human serum showed a 10–12-fold increase in number
within one week and provided an approximate 1000-fold increase
around 3 weeks. In order to fabricate the scaffold system, we should
realize 1) sufﬁcient mechanical strength mimicking native cartilage, 2)
preservation of seeded cells and their even distribution, and 3) good
biocompatibility/biodegradability. To meet with these requirements,
we decided to use the combination of hydrogel and porous scaffolds.
Considering biological effects and clinical availability, atelocollagenmay
be accessible for hydrogel. Next, we investigated the structure and
composition of porous scaffolds. We prepared ones of a classical poly-
mer PLLA or PLGA with various kinds of porosity and pore sizes. The
porous scaffolds possessed sufﬁcient strength even with high porosity
(>95%) and good interconnectivity, which showed favorable cartilage
regeneration when transplanted in the subcutaneous space of nude
mice with chondrocyte/atelocollagen mixture. In order to examine the
biocompatibility, we conducted a canine model for autologous trans-
plantation of the tissue-engineered cartilage, and compared between
such scaffolds of PLLA and PLGA. The tissue-engineered constructs
using PLLA contained abundant cartilage after transplantation,
although the PLGA constructs did not show the cartilage and could not
maintain their shapes. The PLLA scaffolds were suitable for cartilage
tissue engineering under the immunocompetent conditions, because of
the retard at degradation properties and the decrease in the severe
tissue reactions during the early stage of transplantation.
Conclusions: With these technologies, we applied the implant-type
tissue-engineered cartilage for treatment of a nasal deformity in
patients with cleft lip/palate. We would also apply these elemental
techniques for the development of tissue-engineered trachea or joints,
and the preclinical experiments are underway. We hope these tissue-
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present treatment of cartilage diseases.
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PROTEOMICS AS A TOOL FOR STUDYING OSTEOARTHRITIS
D. de Seny. GIGA Res., Univ. of Liège, CHU Liège, Liège, Belgium
Proteomics is the large-scale study of proteins expressed by cells,
tissues or organ. It describes the dynamics of cell regulation by
detecting molecular events related to the development of a disease. It is
a multidisciplinary approach using medical, biological, bioanalytical
and bioinformatics knowledge. One of the most promising applications
of proteomics studies is identiﬁcation of new biomarkers as indicators
of pathogenic processes or pharmacologic responses to a therapeutic
intervention. However, several practical considerations need to be
raised to set up a robust and sensitive strategy for biomarker discovery
in osteoarthritis (OA). OA is a heterogeneous, complex joint pathology.
Progression of OA is slow and periodic with intermittent episodes of
inﬂammatory ﬂares and remission periods. Therefore, biomarkers are
discontinuously released in biological ﬂuids.
This presentation will focus on current proteomic approaches and their
limitations in identifying the so-called soluble or “wet biomarkers”
measured in blood, serum, plasma, urine and synovial ﬂuid. The pres-
ence of a high quantity of proteins in such complex biological ﬂuid
make biomarkers discovery highly challenging. Nevertheless, current
approaches exist to extend accessible concentration range and deep
proteome detection. Comparison between a “targeted proteomic
approach” based in the evaluation of single disease-related molecule
levels and a “non-targeted proteomic approach” based on the simul-
taneous evaluation of hundreds proteins in a blind experiment using
gel-based methods or mass spectrometry will be reviewed. Based on
the assumption that a combination of biomarkers is more speciﬁc and
sensitive for disease diagnosis than single marker, non-targeted pro-
teomic technologies became highly attractive over the last decade.
However, the gap between biomarkers discovery and clinical imple-
mentation remains important, as only few biomarkers have already
been validated. All these practical considerations will be illustrated by
current proteomics studies.
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REHABILITATION FOR CARTILAGE DEFECT IN EARLY KNEE OA
M. Risberg. NAR, Dept. of Sport Med., Norwegian Sch. Sport Sci., Oslo,
Norway
Background: It is well established that treatment and rehabilitation of
patients with knee OA needs to start early in the disease process. Knee
injuries and obesity have shown to be two of the most signiﬁcant
predictors for onset and progression of knee OA largely mediated by
biomechanical forces acting across the knee. Articular cartilage in the
knee is prone to damage by trauma or degeneration and damaged
cartilage is one of the key issues in the OAdisease process. Focal cartilage
defects as well as other major knee injuries affect the mechanical envi-
ronment in the joint possibly through changes in knee articular cartilage
loading. The effect of exercise interventions for reducing symptoms and
improving function in patients with knee OA has been well established,
but the effect of exercise therapy for patients with focal cartilage defects
is spares. Cartilage loading has shown to be signiﬁcant for cartilage
health, however, we lack knowledge on how muscle function affect
cartilage health. Quadriceps muscle strength in particular has shown to
inﬂuence load transmission and absorption across the knee joint
Objective: The objective of this presentation is to go through the
evidence for the effect of exercises for patients with cartilage defect in
early knee OA. Furthermore, the aim is to present the Oslo CARE study
to highlight the need for speciﬁcally descried exercise therapy programs
and how this exercise therapy program have shown to inﬂuence
symptoms, disabilities and cartilage quality using quantitative MRI.
Methods: A narrative literature review will be presented as well as the
development of the exercise therapy program and the outcomes from
the Oslo CARE study. The Oslo CARE study included balance exercises,
balance with resistance, followed by traditionally resistance training
and ﬁnally plyometric exercises for patients with focal cartilage defects.
The exercises aimed at generating muscle strength and power impor-
tant for daily life and sport performance, without a potential deleterious
effect on cartilage health.Results: Clinically patients with focal cartilage defect experience pain,
effusion, muscle weakness and other neuromuscular deﬁcits.
Furthermore, there is a wide range of the type, size and location of the
patients’ focal cartilage defect that should inﬂuence the type of
exercises performed. It has been stated that conservative management
of patients with cartilage defect are inappropriate since they are likely
non-responders to such treatment. There are to our knowledge no
RCTs on the effect of exercise therapy for patients with focal cartilage
defects, but a few studies have examined the effect of exercises after
cartilage repair. Different theories have been proposed for why exer-
cises seem to work for patients with knee OA: neuromuscular, peri-
articular, intra-articular components, general ﬁtness/health, and
psychosocial. Studies seem to support that at least low to moderate
activities and exercises improve function and are not deleterious to
the knee articular cartilage. However, the mechanisms for why exer-
cises seem to affect the patients' symptoms or function are not well
understood. The Oslo CARE study showed that patients with focal
cartilage defects improved knee function over time, without delete-
rious on the knee articular cartilage.
Discussion: We need to increase our focus on why exercises seem to
work for patients with cartilage defects in early knee OA. We need to
move from the palliative treatment of symptoms and dysfunction to
a better understanding of how and if exercises affect the onset and
progression of the knee OA process. Better rehabilitation programs for
patients with focal cartilage defects, patients with signiﬁcant predictors
for development of knee OA, needs to be undertaken. Themuscles of the
lower extremity, particular the quadriceps, have shown to play an
important role in the management of patients with knee OA.
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ROLE OF COMPLEMENT AND INFLAMMATION IN OSTEOARTHRITIS
W. Robinson. VA Palo Alto Hlth. Care System, Palo Alto, CA, USA
Purpose: Although low-grade inﬂammatory responses are observed in
OA, their contribution to its pathogenesis is unclear. We are investi-
gating the role for the complement system and inﬂammation in the
pathogenesis of OA.
Methods: Proteomic studies were performed on OA synovial ﬂuids and
membranes. Murine models of OA were used to further investigate the
role of the complement system and other inﬂammatory mediators.
Results: Through proteomic analyses of synovial ﬂuids and membranes
from individuals with osteoarthritis, we ﬁnd that expression and acti-
vation of complement and other inﬂammatory mediators in human
osteoarthritic joints. Using mice genetically deﬁcient in C5, C6, or
CD59a, we show that complement, and speciﬁcally the membrane
attack complex (MAC)-mediated arm of complement, is critical to the
development of OA. Immunoﬂuorescent staining demonstrated that
MAC co-localized with matrix metalloprotease (MMP)-13 and with
activated extracellular signal-regulated kinase (ERK) around chon-
drocytes in human osteoarthritic cartilage.
Conclusions: Our ﬁndings indicate that dysregulation of complement
and activation of inﬂammatory pathways in synovial joints plays
a critical role in the pathogenesis of osteoarthritis.
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SYNDECAN-4: ENVIRONMENTAL SENSOR AND MATRIX REGULATOR
M.R. Morgan. Univ. of Manchester, Manchester, United Kingdom
Cell migration and microenvironment remodeling are essential for
tissue morphogenesis, homeostasis and repair, and for the pathogenesis
of inﬂammatory, neoplastic and degenerative musculoskeletal diseases.
Adhesion contacts are integrin-mediated complexes that integrate the
extracellular environment with the contractile machinery of the cell.
Precise spatial and temporal coordination of adhesion complex
dynamics is essential to permit efﬁcient cell migration and to regulate
extracellular matrix remodelling.
Differential engagement of a5b1 and aVb3 integrins regulates the
balance between adhesion contact turnover and stabilisation. However,
the mechanisms that dynamically control heterodimer-speciﬁc delivery
of integrins to the cell surface, in order to coordinate adhesion
dynamics, are poorly understood. We have identiﬁed the membrane-
intercalated proteoglycan syndecan-4, which serves a key role in the
development of osteoarthritis, as the regulatory control point that
coordinates integrin recycling.
